Jubilant Biosys

Jubilant Biosys

Jubilant Biosys is a contract research organization (CRO) that provides drug discovery and development services. Its parent is the Jubilant Bhartia Group, an Indian conglomerate with interests including pharmaceuticals, food, and oil and gas. The firm was established to leverage the group's scientific expertise in serving global pharmaceutical and biotechnology companies. The company's services span the drug development value chain: target identification, hit-to-lead chemistry, preclinical development, and clinical trial support. It works across therapeutic areas including oncology, central nervous system disorders, and infectious diseases. The firm's client base includes top 20 pharmaceutical companies as well as emerging biotechs. Jubilant Biosys employs over 1,500 scientists and researchers across its four locations, with the largest research center in Bangalore, India (separate from its Mumbai office). In 2023, the firm expanded its AI/ML capabilities in drug discovery through collaborations with academic partners. The firm's structural differentiator is its integration within the Jubilant Bhartia Group's broader pharmaceutical and chemical manufacturing ecosystem, allowing it to offer seamless transition from discovery through commercial-scale production. This vertical integration gives clients a single provider for drug development from lab to market.